Clinical significance of progenitor cells in multiple myeloma - European Medical Journal

Clinical significance of progenitor cells in multiple myeloma

Hematology
Prof Kenneth Anderson (Harvard Medical School, Boston, MA) chairs a discussion with Prof Leif Bergsagel (Mayo Clinic, Scottsdale, AZ) and Prof Gareth Morgan (University of Arkansas, Fayetteville, AR) on studies of potential new avenues for the treatment of multiple myeloma (MM). They focus on the clinical significance of tumour heterogeneity in MM, the utilisation of genomics for improved classification of MM subtypes and the development of rationally based combination therapies for MM.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now